Literature DB >> 12629646

Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.

Sheng-Nan Lu1, Tsung-Ming Chen, Chuan-Mo Lee, Jing-Houng Wang, Hung-Da Tung, Jaw-Ching Wu.   

Abstract

The molecular epidemiological and clinical aspects of hepatitis D virus (HDV) in a unique HBV, HCV, and HDV triple virus endemic community in southern Taiwan were investigated. A total of 2,909 residents aged 45 or older were screened for hepatitis B surface antigen (HBsAg), anti-HCV antibody, and anti-HDV antibody (specifically for HBsAg-positive carriers). Factors that might be associated with HDV infection, viral nucleic acid detection, and genotyping of HBV, HCV, and HDV were investigated. The prevalence of HBsAg and anti-HCV were 12.6% (366/2,909) and 41.6% (1,227/2,909), respectively. For HBsAg carriers, 15.3% (56/366) were positive for anti-HDV assay. Living in a higher endemic district of HCV infection (odds ratio [OR] = 3.2; 95% confidence interval [CI] = 1.7-6.3), male gender (OR = 1.9; 95% CI = 1.1-3.6) and co-infection with HCV (OR = 1.8; 95% CI = 1.0-3.3) were significantly independent factors associated with HDV infection. The detection rate of HDV RNA among anti-HDV-positive patients was only 12.7% (7/55). The mean HBV titer of triple infection group was significantly lower than in the HBV/HDV co-infection group (2.23 vs 3.05 in log(10), copies/ml, P = 0.046). HCV RNA detection among the triple infection group showed 47.4% (9/19) viremia rate and viral loads of 579,121 IU/ml in median (16,803-1,551,190 IU/ml). The prevalent genotype of HBV was type B (23/25); HCV was 1b (7/9) and HDV was IIa/IIb (4/4). Only the presence of HCV RNA predicted the presence of elevated ALT significantly (OR = 25.0; 95% CI = 3.39-184.6). In conclusion, the geographical aggregation of HDV infection paralleled that of HCV infection in this community. HCV suppressed the replication of HBV among triple vital infection patients. HBV and HDV lapsed into a remission or nonreplicative phase in most cases, and HCV acted as a dominant factor in triple viral-infected individuals. Only the presence of HCV RNA was associated with elevated ALT values, but not HBV or HDV. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629646     DOI: 10.1002/jmv.10361

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  New enzyme-linked immunosorbent assay for detection of antibodies against hepatitis delta virus using a hepatitis delta antigen derived from a Taiwanese clone and comparison to the Abbott radioimmunoassay.

Authors:  Yung-Bin Kuo; Mei Chao; Yi-Hsuan Lee; Chau-Ting Yeh; Err-Cheng Chan
Journal:  Clin Vaccine Immunol       Date:  2012-03-07

2.  Hepatitis D infection: from initial discovery to current investigational therapies.

Authors:  Ben L Da; Theo Heller; Christopher Koh
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-23

3.  Is hepatitis C virus core antigen an adequate marker for community screening?

Authors:  Yuan-Hung Kuo; Kuo-Chin Chang; Jing-Houng Wang; Pei-Shan Tsai; Shu-Feng Hung; Chao-Hung Hung; Chien-Hung Chen; Sheng-Nan Lu
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

Review 4.  Hepatitis D: Scenario in the Asia-Pacific region.

Authors:  Zaigham Abbas; Wasim Jafri; Sajjad Raza
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

5.  Evaluation of mental health and anxiety level among hepatitis C patients during COVID-19 pandemic in Pakistan.

Authors:  Sadia Rafique; Muhammad Saleem Khan; Rabia Unar; Muhammad Wajid; Ahmad Waheed; Ali Umar
Journal:  Egypt Liver J       Date:  2021-06-12

6.  Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community.

Authors:  Kuo-Chin Chang; Pei-Shan Tsai; Mei-Chin Hsu; Shu-Fen Hung; Chin-Chen Tsai; Sheng-Nan Lu
Journal:  J Gastroenterol       Date:  2010-01-07       Impact factor: 7.527

Review 7.  An overview of triple infection with hepatitis B, C and D viruses.

Authors:  Mehwish Riaz; Muhamad Idrees; Hifza Kanwal; Firoz Kabir
Journal:  Virol J       Date:  2011-07-27       Impact factor: 4.099

8.  High prevalence and significance of hepatitis D virus infection among treatment-naïve HBsAg-positive patients in Northern Vietnam.

Authors:  Bui Tien Sy; Boris A Ratsch; Nguyen Linh Toan; Le Huu Song; Christian Wollboldt; Agnes Bryniok; Hung Minh Nguyen; Hoang Van Luong; Thirumalaisamy P Velavan; Heiner Wedemeyer; Peter G Kremsner; C-Thomas Bock
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

9.  Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, China.

Authors:  Baolin Liao; Fuchun Zhang; Siwei Lin; Haolan He; Yu Liu; Jiansheng Zhang; Ying Xu; Junqing Yi; Yunqing Chen; Huiyuan Liu; Zhanhui Wang; Weiping Cai
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

10.  Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam.

Authors:  Hung Minh Nguyen; Bui Tien Sy; Nguyen Thanh Trung; Nghiem Xuan Hoan; Heiner Wedemeyer; Thirumalaisamy P Velavan; C-Thomas Bock
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.